연구성과로 돌아가기
2025 연구성과별 연구자 정보 (318 / 1187)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| Dual-controlled piezoelectric composite film with enhanced crystallinity and defect-free via solvent vapor treatment | Park, Kwi-Il | Park, KI | 9 | 교신저자 | Kyungpook Natl Univ, Innovat Semicond Educ & Res Ctr Future Mobil, 80 Daehak Ro, Daegu 41566, South Korea | LKN-9445-2024 | Park, Kwiil | 0000-0002-9140-6641 | Park, Kwi-Il | kipark@knu.ac.kr; |
| Dual-controlled piezoelectric composite film with enhanced crystallinity and defect-free via solvent vapor treatment | Park, Kwi-Il | Park, KI | 9 | 교신저자 | Kyungpook Natl Univ, Res Inst Automot Parts & Mat, 80 Daehak Ro, Daegu 41566, South Korea | LKN-9445-2024 | Park, Kwiil | 0000-0002-9140-6641 | Park, Kwi-Il | kipark@knu.ac.kr; |
| Dual-Modal Sensing Skin Adaptive to Daylight, Darkness, and Ultraviolet Light for Simultaneous Full-Field Deformation Measurement and Mechanoluminescence Responses | Timilsina, Suman | Timilsina, S | 1 | Kyungpook Natl Univ, KNU Res Inst Artificial Intelligent Diag Technol M, Kyeongbuk 37224, South Korea | GLT-8029-2022 | Timilisina, Suman | 0000-0003-3362-9369 | Timilsina, Suman | khl@knu.ac.kr; kssohn@sejong.ac.kr; jisikkim@knu.ac.kr; | |
| Dual-Modal Sensing Skin Adaptive to Daylight, Darkness, and Ultraviolet Light for Simultaneous Full-Field Deformation Measurement and Mechanoluminescence Responses | Jo, Cheol Woo | Jo, CW | 2 | Kyungpook Natl Univ, Sch Adv Sci & Technol Convergence, Kyeongbuk 37224, South Korea | khl@knu.ac.kr; kssohn@sejong.ac.kr; jisikkim@knu.ac.kr; | |||||
| Dual-Modal Sensing Skin Adaptive to Daylight, Darkness, and Ultraviolet Light for Simultaneous Full-Field Deformation Measurement and Mechanoluminescence Responses | Lee, Kwang Ho | Lee, KH | 3 | 교신저자 | Kyungpook Natl Univ, Dept Automot Engn, Kyeongbuk 37224, South Korea | khl@knu.ac.kr; kssohn@sejong.ac.kr; jisikkim@knu.ac.kr; | ||||
| Dual-Modal Sensing Skin Adaptive to Daylight, Darkness, and Ultraviolet Light for Simultaneous Full-Field Deformation Measurement and Mechanoluminescence Responses | Sohn, Kee-Sun | Sohn, KS | 4 | 교신저자 | Sejong Univ, Nanotechnol & Adv Mat Engn, 209 Neungdong Ro, Seoul 143747, South Korea | khl@knu.ac.kr; kssohn@sejong.ac.kr; jisikkim@knu.ac.kr; | ||||
| Dual-Modal Sensing Skin Adaptive to Daylight, Darkness, and Ultraviolet Light for Simultaneous Full-Field Deformation Measurement and Mechanoluminescence Responses | Kim, Ji Sik | Kim, JS | 5 | 교신저자 | Kyungpook Natl Univ, Sch Nano & Adv Mat Engn, Kyeongbuk 37224, South Korea | 0000-0002-1432-8176 | Kim, jisik | khl@knu.ac.kr; kssohn@sejong.ac.kr; jisikkim@knu.ac.kr; | ||
| Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study | Sangro, Bruno | Sangro, B | 1 | 교신저자 | Clin Univ Navarra, Liver Unit, Pamplona 31008, Spain | AFW-4106-2022 | Sangro, Bruno | bsangro@unav.es; | ||
| Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study | Sangro, Bruno | Sangro, B | 1 | 교신저자 | Clin Univ Navarra, HPB Oncol Area, Pamplona 31008, Spain | AFW-4106-2022 | Sangro, Bruno | bsangro@unav.es; | ||
| Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study | Sangro, Bruno | Sangro, B | 1 | 교신저자 | CIBEREHD, Pamplona 31008, Spain | AFW-4106-2022 | Sangro, Bruno | bsangro@unav.es; | ||
| Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study | Kudo, Masatoshi | Kudo, M | 2 | Kindai Univ, Dept Gastroenterol & Hepatol, Fac Med, Osaka, Japan | AAA-9744-2019 | Kudo, Masatoshi | bsangro@unav.es; | |||
| Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study | Erinjeri, Joseph P. | Erinjeri, JP | 3 | Mem Sloan Kettering Canc Ctr, Intervent Radiol Serv, New York, NY USA | bsangro@unav.es; | |||||
| Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study | Qin, Shukui | Qin, SK | 4 | Jinling Hosp, Canc Ctr Nanjing, Nanjing, Peoples R China | bsangro@unav.es; | |||||
| Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study | Ren, Zhenggang | Ren, ZG | 5 | Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Dept Hepat Oncol, Shanghai, Peoples R China | bsangro@unav.es; | |||||
| Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study | Chan, Stephen L. | Chan, SL | 6 | Chinese Univ Hong Kong, Prince Wales Hosp, Sir Yue kong Pao Ctr Canc, Dept Clin Oncol, Hong Kong, Peoples R China | F-9149-2011 | Chan, Stephen | bsangro@unav.es; |
페이지 이동: